These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12522089)

  • 1. In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain.
    Ruiu S; Marchese G; Saba PL; Satta R; Gessa G; Vaccari A; Pani L
    Br J Pharmacol; 2003 Jan; 138(1):188-92. PubMed ID: 12522089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia.
    Wright AM; Bempong J; Kirby ML; Barlow RL; Bloomquist JR
    Brain Res; 1998 Mar; 788(1-2):215-22. PubMed ID: 9555021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.
    Brand L; Oliver DW; van der Schyf CJ; Pond SM; Castagnoli N
    Life Sci; 1996; 59(10):815-20. PubMed ID: 8761315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP.
    Igarashi K; Kasuya F; Fukui M; Usuki E; Castagnoli N
    Life Sci; 1995 Nov; 57(26):2439-46. PubMed ID: 8847965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of haloperidol and its metabolites on dopamine and noradrenaline uptake in rat brain slices.
    Fang J; Yu PH
    Psychopharmacology (Berl); 1995 Oct; 121(3):379-84. PubMed ID: 8584621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
    Usuki E; Pearce R; Parkinson A; Castagnol N
    Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies.
    Bloomquist J; King E; Wright A; Mytilineou C; Kimura K; Castagnoli K; Castagnoli N
    J Pharmacol Exp Ther; 1994 Aug; 270(2):822-30. PubMed ID: 8071874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.
    Norrholm SD; Horton DB; Dwoskin LP
    Neuropharmacology; 2007 Dec; 53(8):982-9. PubMed ID: 18022203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by tetanus toxin of sodium-dependent, high-affinity [3H]5-hydroxytryptamine uptake in rat synaptosomes.
    Inserte J; Najib A; Pelliccioni P; Gil C; Aguilera J
    Biochem Pharmacol; 1999 Jan; 57(1):111-20. PubMed ID: 9920291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of nitric oxide on the uptake of [3H]dopamine and [3H]glutamate by striatal synaptosomes.
    Lonart G; Johnson KM
    J Neurochem; 1994 Dec; 63(6):2108-17. PubMed ID: 7964730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of [3H]vesamicol binding in rat brain preparations.
    Meyer EM; Bryant SO; Wang RH; Watson RJ
    Neurochem Res; 1993 Oct; 18(10):1067-72. PubMed ID: 8255355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and metabolism of [3H]choline mustard by cholinergic nerve terminals from rat brain.
    Rylett RJ; Walters SA
    Neuroscience; 1990; 36(2):483-9. PubMed ID: 2215931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol treatment impairs glutamate transport in the rat striatum.
    De Souza IE; McBean GJ; Meredith GE
    Eur J Pharmacol; 1999 Oct; 382(2):139-42. PubMed ID: 10528149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of rat brain synaptosomal [3H]hemicholinium-3 binding and [3H]choline transport sites following exposure to choline mustard aziridinium ion.
    Ferguson SS; Rylett RJ; Collier B
    J Neurochem; 1994 Oct; 63(4):1328-37. PubMed ID: 7931285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine.
    Ferraro L; Beggiato S; Marcellino D; Frankowska M; Filip M; Agnati LF; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K
    J Neural Transm (Vienna); 2010 May; 117(5):593-7. PubMed ID: 20354886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J; Mactutus CF; Wallace DR; Booze RM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1071-83. PubMed ID: 19325033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain receptors for antipsychotic drugs and dopamine: direct binding assays.
    Seeman P; Chau-Wong M; Tedesco J; Wong K
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4376-80. PubMed ID: 1060115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex.
    Williams JM; Steketee JD
    J Neurosci Methods; 2004 Aug; 137(2):161-5. PubMed ID: 15262056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H+/peptide transporter PEPT2.
    Fujita T; Kishida T; Wada M; Okada N; Yamamoto A; Leibach FH; Ganapathy V
    Brain Res; 2004 Jan; 997(1):52-61. PubMed ID: 14715149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CYP3A in haloperidol N-dealkylation and pharmacokinetics in rats.
    Watanabe M; Tateishi T; Asoh M; Nakura H; Tanaka M; Kumai T; Kobayashi S
    Fundam Clin Pharmacol; 1999; 13(3):337-42. PubMed ID: 10392310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.